Bayer has agreed terms for its first biopharma acquisition in years, paying $300 million upfront for privately-held US ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results